| Literature DB >> 32032364 |
Eszter Kovács1, Judit Sahin-Tóth1, Adrienn Tóthpál1, Mark van der Linden2, Tamás Tirczka3, Orsolya Dobay1.
Abstract
BACKGROUND: The nasopharynx can from time to time accommodate otherwise pathogenic bacteria. This phenomenon is called asymptomatic carriage. However, in case of decreased immunity, viral infection or any other enhancing factors, severe disease can develop. Our aim in this study was to survey the nasal carriage rates of four important respiratory pathogens in three different age groups of children attending nurseries, day-care centres and primary schools. This is the first study from Hungary about the asymptomatic carriage of H. influenzae and M. catarrhalis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32032364 PMCID: PMC7006921 DOI: 10.1371/journal.pone.0229021
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Carriage prevalence changes of the four bacterial species related to age.
Colonisation rates of the four respiratory pathogens alone and in combination in the three different age groups.
| Nurseries (1-3y) | DCCs (3-6y) | Primary school (6-13y) | ||||
|---|---|---|---|---|---|---|
| Non-carriers | 54 | (16.1%) | 60 | (32.3%) | 24 | (41.4%) |
| Carriers | 282 | (83.9%) | 126 | (67.7%) | 34 | (58.6%) |
| Carriers of one pathogen | 109 | (32.4%) | 71 | (38.2%) | 28 | (48.3%) |
| 10 | (3.0%) | 30 | (16.1%) | 24 | (41.4%) | |
| 26 | (7.7%) | 9 | (4.8%) | 1 | (1.7%) | |
| 54 | (16.1%) | 28 | (15.1%) | 3 | (5.2%) | |
| 19 | (5.7%) | 4 | (2.2%) | 0 | (0.0%) | |
| Carriers of two pathogens | 111 | (33.0%) | 38 | (20.4%) | 4 | (6.9%) |
| 2 | (0.6%) | 3 | (1.6%) | 0 | (0.0%) | |
| 61 | (18.2%) | 8 | (4.3%) | 1 | (1.7%) | |
| 17 | (5.1%) | 5 | (2.7%) | 0 | (0.0%) | |
| 20 | (6.0%) | 9 | (4.8%) | 0 | (0.0%) | |
| 8 | (2.4%) | 10 | (5.4%) | 3 | (5.2%) | |
| 3 | (0.9%) | 3 | (1.6%) | 0 | (0.0%) | |
| Carriers of three pathogens | 60 | (17.9%) | 12 | (6.5%) | 2 | (3.4%) |
| 47 | (14.0%) | 7 | (3.8%) | 0 | (0.0%) | |
| 6 | (1.8%) | 1 | (0.5%) | 2 | (3.4%) | |
| 3 | (0.9%) | 2 | (1.1%) | 0 | (0.0%) | |
| 4 | (1.2%) | 2 | (1.1%) | 0 | (0.0%) | |
| Carriers of four pathogens | 2 | (0.6) | 5 | (2.7%) | 0 | (0.0%) |
Fig 2Carriage rates of three bacterial species together.
Statistical associations of co-carriage between the four species.
| p-value | p-value | p-value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Carriers | Non-carriers | Carriers | Non-carriers | Carriers | Non-carriers | ||||
| 26 (12.5) | 182 (87.5) | 88 (42.3) | 120 (57.7) | 140 (67.3) | 68 | ||||
| 97 | 275 (73.9) | 64 (17.2) | 308 (82.8) | 141 (37.9) | 231 (62.1) | ||||
| VT | 2 | 11 | 0.669 | 6 | 7 | 0.780 | 9 (69.2) | 4 | 1.000 (NS) |
| NVT | 24 (12.3) | 171 (87.7) | 82 (42.1) | 113 (57.9) | 131 (67.2) | 64 | |||
| - | - | - | 24 (19.5) | 99 (80.5) | 0.065 (NS) | 43 (35.0) | 80 (65.0) | ||
| - | - | 128 (28.0) | 329 (72.0) | 238 (52.1) | 219 (47.9) | ||||
| - | - | - | - | - | - | 96 (63.2) | 56 (36.8) | ||
| - | - | - | - | 185 (43.2) | 243 (56.8) | ||||
*VT = PCV13 type
Cumulative table of correlation between carriage and possible risk factors.
| Risk factor | Pathogen | Screened children (1-13y) n = 576 | p-value | |
|---|---|---|---|---|
| Carriers (%) | NCs (%) | |||
| Gender male | 101 (35.1) | 187 (64.9) | 0.794 (NS) | |
| Gender female | 105 (36.5) | 183 (63.5) | ||
| Having siblings | 129 (34.2) | 248 (65.8) | 0.315 (NS) | |
| Not having siblings | 77 (38.7) | 122 (61.3) | ||
| Antibiotic exposure in the past two weeks | 49 (34.5) | 93 (65.5) | 0.763 (NS) | |
| No antibiotics | 157 (36.2) | 277 (63.8) | ||
| Passive exposure to smoking | 51 (29.0) | 125 (71.0) | ||
| No passive exposure to smoking | 155 (38.8) | 245 (61.3) | ||
| Total number of carriers and NCs | 206 (35.8) | 370 (64.2) | ||
*: Data of four children attending nursery were missing
NC: non-carrier
PCV13, PPV23 and NVT serotype distribution among the three groups.
| Serotype | Nurseries (1-3y) | DCCs (3-6y) | Primary school (6-13y) |
|---|---|---|---|
| PCV13 serotypes | |||
| 7F | 0 (0.0) | 0 (0.0) | 1 (25.0) |
| 9V | 0 (0.0) | 1 (2.4) | 0 (0.0) |
| 19A | 1 (0.6) | 0 (0.0) | 0 (0.0) |
| 19F | 7 (4.2) | 3 (7.3) | 0 (0.0) |
| PPV23 serotypes | |||
| 9N | 5 (3.0) | 0 (0.0) | 0 (0.0) |
| 10A | 9 (5.5) | 2 (4.9) | 0 (0.0) |
| 11A | 11 (6.7) | 11 (26.8) | 0 (0.0) |
| 15B | 28 (17.0) | 2 (4.9) | 0 (0.0) |
| 17F | 0 (0.0) | 1 (2.4) | 0 (0.0) |
| 22F | 1 (0.6) | 0 (0.0) | 0 (0.0) |
| 33F | 3 (1.8) | 0 (0.0) | 0 (0.0) |
| NVT serotypes | |||
| 6C | 3 (1.8) | 4 (9.8) | 0 (0.0) |
| 15A | 10 (6.1) | 0 (0.0) | 0 (0.0) |
| 15C | 12 (7.3) | 3 (7.3) | 0 (0.0) |
| 21 | 3 (1.8) | 0 (0.0) | 0 (0.0) |
| 23A | 14 (8.5) | 0 (0.0) | 0 (0.0) |
| 23B | 4 (2.4) | 4 (9.8) | 1 (25.0) |
| 24F | 19 (11.5) | 0 (0.0) | 0 (0.0) |
| 31 | 0 (0.0) | 3 (7.3) | 0 (0.0) |
| 34 | 5 (3.0) | 1 (2.4) | 0 (0.0) |
| 35B | 7 (4.2) | 3 (7.3) | 0 (0.0) |
| 35F | 16 (9.7) | 1 (2.4) | 0 (0.0) |
| 37 | 0 (0.0) | 0 (0.0) | 2 (50.0) |
| 38 | 4 (2.4) | 0 (0.0) | 0 (0.0) |
| NT | 3 (1.8) | 2 (4.9) | 0 (0.0) |
| Total PCV13 | 8 (4.8) | 4 (9.8) | 1 (25.0) |
| Total PPV23 | 57 (34.5) | 16 (39.0) | 0 (0.0) |
| Total NVT | 100 (60.6) | 21 (51.2) | 3 (75.0) |
n: number of isolates
Fig 3Summarized serotype distribution of the pneumococci from this study (n = 210).
Red bars, PCV13 serotypes; Yellow bars, PPV23 serotypes; blue bars, NVT serotypes.
Summarized antibiotic susceptibility data of the bacterial isolates from this study.
| Bacteria (n) and antibiotics | MIC range | MIC50 (mg/L) | MIC90 (mg/L) | S (%) | I (%) | R (%) |
|---|---|---|---|---|---|---|
| Penicillin | <0.015–2 | 0.03 | 0.25 | 86.7 | 13.3 | 0.0 |
| Cefotaxime | <0.004–1 | 0.03 | 0.125 | 96.2 | 3.8 | 0.0 |
| Imipenem | <0.004–0.5 | 0.015 | 0.06 | 100.0 | 0.0 | 0.0 |
| Erythromycin | <0.06->256 | 0.125 | 32 | 82.9 | 0.0 | 17.1 |
| Clindamycin | <0.5->128 | <0.5 | <0.5 | 91.9 | 0.0 | 8.1 |
| Levofloxacin | <0.5–2 | 1 | 2 | 100.0 | 0.0 | 0.0 |
| Moxifloxacin | <0.03–0.5 | 0.25 | 0.25 | 100.0 | 0.0 | 0.0 |
| Vancomycin | <0.125–1 | 0.5 | 1 | 100.0 | 0.0 | 0.0 |
| Penicillin | <0.03–256 | 8 | 64 | 22.8 | 0.0 | 77.2 |
| Oxacillin | 0.06–0.5 | 0.25 | 0.5 | 100.0 | 0.0 | 0.0 |
| Tetracycline | 0.25->4 | 0.5 | 1 | 98.4 | 0.0 | 1.6 |
| Erythromycin | 0.19->256 | 0.19 | >256 | 87.8 | 0.0 | 12.2 |
| Clindamycin | 0.094–1 | 0.094 | 0.25 | 99.2 | 0.0 | 0.8 |
| Gentamicin | 0.5–4 | 1 | 1 | 95.1 | 0.0 | 4.9 |
| Ciprofloxacin | 0.25–2 | 0.5 | 1 | 99.2 | 0.0 | 0.8 |
| Mupirocin | <0.03->1024 | 0.06 | 0.06 | 97.6 | 0.0 | 2.4 |
| Vancomycin | 1–2 | 1 | 2 | 100.0 | 0.0 | 0.0 |
| Ampicillin | 0.25->8 | 1 | 1 | 93.4 | 0.0 | 6.6 |
| Amoxicillin-clavulanic acid | 0.125–0.75 | 0.5 | 0.5 | 100.0 | 0.0 | 0.0 |
| Cefotaxime | 0.008–0.06 | 0.015 | 0.06 | 100.0 | 0.0 | 0.0 |
| Levofloxacin | <0.004–0.125 | 0.008 | 0.015 | 100.0 | 0.0 | 0.0 |
| Moxifloxacin | <0.004–0.5 | 0.03 | 0.06 | 100.0 | 0.0 | 0.0 |
| Erythromycin | <0.25–32 | 8 | 16 | 96.7 | 0.0 | 3.3 |
| Azithromycin | 0.06–8 | 2 | 4 | 90.8 | 0.0 | 9.2 |
| Trimethoprim-sulfamethoxazole | 0.008->32 | 0.03 | >32 | 85.5 | 0.0 | 14.5 |
| Amoxicillin-clavulanic acid | <0.06–0.38 | 0.094 | 0.25 | 100.0 | 0.0 | 0.0 |
| Cefotaxime | <0.004–1 | 0.25 | 0.5 | 100.0 | 0.0 | 0.0 |
| Levofloxacin | 0.015–0.5 | 0.03 | 0.06 | 98.2 | 0.0 | 1.8 |
| Moxifloxacin | 0.06–0.25 | 0.06 | 0.125 | 100.0 | 0.0 | 0.0 |
| Erythromycin | <0.125–16 | 0.25 | 0.25 | 96.1 | 2.5 | 1.4 |
| Azithromycin | <0.06–8 | 0.06 | 0.06 | 97.9 | 0.4 | 1.8 |
| Trimethoprim-sulfamethoxazole | 0.015–2 | 0.125 | 0.25 | 98.9 | 0.4 | 0.7 |
Fig 4PFGE pattern of the serotype f and e H. influenzae isolates.
Fig 5PFGE pattern of the three mupirocin resistant S. aureus isolates.
Fig 6PFGE dendrogram of the serotype 11A pneumococcal isolates from this study.